cinacalcet has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Ge, F; He, Q; Qian, M; Weng, Q; Yang, B; Zheng, L; Zhu, H | 1 |
1 other study(ies) available for cinacalcet and Hepatocellular Carcinoma
| Article | Year |
|---|---|
The calcimimetic agent cinacalcet inhibits hepatocellular carcinoma via YAP/TAZ suppression.
Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Hepatocellular; Cinacalcet; Humans; Liver Neoplasms; Signal Transduction; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; YAP-Signaling Proteins | 2021 |